Literature DB >> 9672387

mRNA coding for voltage-gated sodium channel beta2 subunit in rat central nervous system: cellular distribution and changes following kainate-induced seizures.

M Gastaldi1, A Robaglia-Schlupp, A Massacrier, R Planells, P Cau.   

Abstract

The cellular distribution of sodium channel beta2 subunit mRNA was examined in the central nervous system from adult Wistar rats using a non-radioactive in situ hybridization method with digoxigenin-labeled cRNA probes. The expression of the subunit was strong in cerebral and cerebellar cortex, in medulla oblongata and in the spinal cord whereas heterogeneous in hippocampus. The distribution was evaluated in hippocampus and cerebral cortex from 1 to 72 h after kainate injection and compared to control rats using densitometric analysis. In these areas, a transient increase was seen 1 h after the drug administration, followed, in the hippocampus, by a significant decrease. These variations differ from those we previously reported for alpha subunits and might play a role in cellular excitability changes occurring in the course of seizures.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9672387     DOI: 10.1016/s0304-3940(98)00394-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

1.  Regulation of Nav1.6 and Nav1.8 peripheral nerve Na+ channels by auxiliary β-subunits.

Authors:  Juan Zhao; Michael E O'Leary; Mohamed Chahine
Journal:  J Neurophysiol       Date:  2011-05-11       Impact factor: 2.714

Review 2.  Voltage-gated sodium channel β subunits: The power outside the pore in brain development and disease.

Authors:  Jacob M Hull; Lori L Isom
Journal:  Neuropharmacology       Date:  2017-09-18       Impact factor: 5.250

3.  Distinct gene expression profiles directed by the isoforms of the transcription factor neuron-restrictive silencer factor in human SK-N-AS neuroblastoma cells.

Authors:  Stuart G Gillies; Kate Haddley; Sylvia A Vasiliou; Gregory M Jacobson; Bengt von Mentzer; Vivien J Bubb; John P Quinn
Journal:  J Mol Neurosci       Date:  2010-07-23       Impact factor: 3.444

4.  Eslicarbazepine, but Not Lamotrigine or Ranolazine, Shows Anticonvulsant Efficacy in Carbamazepine-Resistant Rats Developed by Window-Pentylenetetrazole Kindling.

Authors:  Cecilia Zavala-Tecuapetla; Joaquín Manjarrez-Marmolejo; Josué Orlando Ramírez-Jarquín; Claudia Verónica Rivera-Cerecedo
Journal:  Brain Sci       Date:  2022-05-11

5.  Rapid loss of efficacy to the antiseizure drugs lamotrigine and carbamazepine: a novel experimental model of pharmacoresistant epilepsy.

Authors:  Ajay K Srivastava; Anitha B Alex; Karen S Wilcox; H Steve White
Journal:  Epilepsia       Date:  2013-06-10       Impact factor: 5.864

6.  Regulatory Role of Voltage-Gated Na Channel β Subunits in Sensory Neurons.

Authors:  Mohamed Chahine; Michael E O'Leary
Journal:  Front Pharmacol       Date:  2011-11-21       Impact factor: 5.810

7.  Molecular identity of axonal sodium channels in human cortical pyramidal cells.

Authors:  Cuiping Tian; Kaiyan Wang; Wei Ke; Hui Guo; Yousheng Shu
Journal:  Front Cell Neurosci       Date:  2014-09-23       Impact factor: 5.505

Review 8.  Adult Neurogenesis in Epileptogenesis: An Update for Preclinical Finding and Potential Clinical Translation.

Authors:  Liying Chen; Yi Wang; Zhong Chen
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

9.  Sodium channel β2 subunit promotes filopodia-like processes and expansion of the dendritic tree in developing rat hippocampal neurons.

Authors:  Marta Maschietto; Stefano Girardi; Marco Dal Maschio; Michele Scorzeto; Stefano Vassanelli
Journal:  Front Cell Neurosci       Date:  2013-01-25       Impact factor: 5.505

10.  Identification of both GABAA receptors and voltage-activated Na(+) channels as molecular targets of anticonvulsant α-asarone.

Authors:  Ze-Jun Wang; Simon R Levinson; Liqin Sun; Thomas Heinbockel
Journal:  Front Pharmacol       Date:  2014-03-11       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.